352 related articles for article (PubMed ID: 33242662)
21. Microglial markers in the frontal cortex are related to cognitive dysfunctions in major depressive disorder.
Li H; Sagar AP; Kéri S
J Affect Disord; 2018 Dec; 241():305-310. PubMed ID: 30142589
[TBL] [Abstract][Full Text] [Related]
22. Activated Microglia in the Early Stage of a Rat Model of Parkinson's Disease: Revealed by PET-MRI Imaging by [
Ye P; Bi L; Yang M; Qiu Y; Huang G; Liu Y; Hou Y; Li Z; Yee Tong HH; Cui M; Jin H
ACS Chem Neurosci; 2023 Jun; 14(11):2183-2192. PubMed ID: 37134001
[TBL] [Abstract][Full Text] [Related]
23. Development of a novel radioligand for imaging 18-kD translocator protein (TSPO) in a rat model of Parkinson's disease.
Wu CY; Chen YY; Lin JJ; Li JP; Chen JK; Hsieh TC; Kao CH
BMC Med Imaging; 2019 Sep; 19(1):78. PubMed ID: 31533645
[TBL] [Abstract][Full Text] [Related]
24. Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation.
Chauveau F; Van Camp N; Dollé F; Kuhnast B; Hinnen F; Damont A; Boutin H; James M; Kassiou M; Tavitian B
J Nucl Med; 2009 Mar; 50(3):468-76. PubMed ID: 19223401
[TBL] [Abstract][Full Text] [Related]
25. Imaging microglial/macrophage activation in spinal cords of experimental autoimmune encephalomyelitis rats by positron emission tomography using the mitochondrial 18 kDa translocator protein radioligand [¹⁸F]DPA-714.
Abourbeh G; Thézé B; Maroy R; Dubois A; Brulon V; Fontyn Y; Dollé F; Tavitian B; Boisgard R
J Neurosci; 2012 Apr; 32(17):5728-36. PubMed ID: 22539835
[TBL] [Abstract][Full Text] [Related]
26. Extrastriatal spreading of microglial activation in Parkinson's disease: a positron emission tomography study.
Terada T; Yokokura M; Yoshikawa E; Futatsubashi M; Kono S; Konishi T; Miyajima H; Hashizume T; Ouchi Y
Ann Nucl Med; 2016 Oct; 30(8):579-87. PubMed ID: 27299437
[TBL] [Abstract][Full Text] [Related]
27. Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes.
Setiawan E; Wilson AA; Mizrahi R; Rusjan PM; Miler L; Rajkowska G; Suridjan I; Kennedy JL; Rekkas PV; Houle S; Meyer JH
JAMA Psychiatry; 2015 Mar; 72(3):268-75. PubMed ID: 25629589
[TBL] [Abstract][Full Text] [Related]
28. Optimal Acquisition Time Window and Simplified Quantification of Dopamine Transporter Availability Using 18F-FE-PE2I in Healthy Controls and Parkinson Disease Patients.
Sonni I; Fazio P; Schain M; Halldin C; Svenningsson P; Farde L; Varrone A
J Nucl Med; 2016 Oct; 57(10):1529-1534. PubMed ID: 27230923
[TBL] [Abstract][Full Text] [Related]
29. Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study.
Stokholm MG; Iranzo A; Østergaard K; Serradell M; Otto M; Svendsen KB; Garrido A; Vilas D; Borghammer P; Santamaria J; Møller A; Gaig C; Brooks DJ; Tolosa E; Pavese N
Lancet Neurol; 2017 Oct; 16(10):789-796. PubMed ID: 28684245
[TBL] [Abstract][Full Text] [Related]
30. Imaging Striatal Microglial Activation in Patients with Parkinson's Disease.
Koshimori Y; Ko JH; Mizrahi R; Rusjan P; Mabrouk R; Jacobs MF; Christopher L; Hamani C; Lang AE; Wilson AA; Houle S; Strafella AP
PLoS One; 2015; 10(9):e0138721. PubMed ID: 26381267
[TBL] [Abstract][Full Text] [Related]
31. Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT.
Davis MR; Votaw JR; Bremner JD; Byas-Smith MG; Faber TL; Voll RJ; Hoffman JM; Grafton ST; Kilts CD; Goodman MM
J Nucl Med; 2003 Jun; 44(6):855-61. PubMed ID: 12791810
[TBL] [Abstract][Full Text] [Related]
32. Detection of microglial activation in an acute model of neuroinflammation using PET and radiotracers 11C-(R)-PK11195 and 18F-GE-180.
Dickens AM; Vainio S; Marjamäki P; Johansson J; Lehtiniemi P; Rokka J; Rinne J; Solin O; Haaparanta-Solin M; Jones PA; Trigg W; Anthony DC; Airas L
J Nucl Med; 2014 Mar; 55(3):466-72. PubMed ID: 24516258
[TBL] [Abstract][Full Text] [Related]
33. Elevated Translocator Protein in Anterior Cingulate in Major Depression and a Role for Inflammation in Suicidal Thinking: A Positron Emission Tomography Study.
Holmes SE; Hinz R; Conen S; Gregory CJ; Matthews JC; Anton-Rodriguez JM; Gerhard A; Talbot PS
Biol Psychiatry; 2018 Jan; 83(1):61-69. PubMed ID: 28939116
[TBL] [Abstract][Full Text] [Related]
34. Microglia imaging in methamphetamine use disorder: a positron emission tomography study with the 18 kDa translocator protein radioligand [F-18]FEPPA.
Rathitharan G; Truong J; Tong J; McCluskey T; Meyer JH; Mizrahi R; Warsh J; Rusjan P; Kennedy JL; Houle S; Kish SJ; Boileau I
Addict Biol; 2021 Jan; 26(1):e12876. PubMed ID: 32017280
[TBL] [Abstract][Full Text] [Related]
35. State-associated changes in longitudinal [
De Picker L; Ottoy J; Verhaeghe J; Deleye S; Wyffels L; Fransen E; Kosten L; Sabbe B; Coppens V; Timmers M; de Boer P; Van Nueten L; Op De Beeck K; Oberacher H; Vanhoenacker F; Ceyssens S; Stroobants S; Staelens S; Morrens M
Brain Behav Immun; 2019 Mar; 77():46-54. PubMed ID: 30503836
[TBL] [Abstract][Full Text] [Related]
36. Longitudinal positron emission tomography and postmortem analysis reveals widespread neuroinflammation in SARS-CoV-2 infected rhesus macaques.
Nieuwland JM; Nutma E; Philippens IHCHM; Böszörményi KP; Remarque EJ; Bakker J; Meijer L; Woerdman N; Fagrouch ZC; Verstrepen BE; Langermans JAM; Verschoor EJ; Windhorst AD; Bontrop RE; de Vries HE; Stammes MA; Middeldorp J
J Neuroinflammation; 2023 Jul; 20(1):179. PubMed ID: 37516868
[TBL] [Abstract][Full Text] [Related]
37. Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study.
Rakshi JS; Uema T; Ito K; Bailey DL; Morrish PK; Ashburner J; Dagher A; Jenkins IH; Friston KJ; Brooks DJ
Brain; 1999 Sep; 122 ( Pt 9)():1637-50. PubMed ID: 10468504
[TBL] [Abstract][Full Text] [Related]
38. [
Kim K; Kim H; Bae SH; Lee SY; Kim YH; Na J; Lee CH; Lee MS; Ko GB; Kim KY; Lee SH; Song IH; Cheon GJ; Kang KW; Kim SE; Chung JK; Kim EE; Paek SH; Lee JS; Lee BC; Youn H
Theranostics; 2020; 10(20):9315-9331. PubMed ID: 32802194
[TBL] [Abstract][Full Text] [Related]
39. Microglial activation and dopamine terminal loss in early Parkinson's disease.
Ouchi Y; Yoshikawa E; Sekine Y; Futatsubashi M; Kanno T; Ogusu T; Torizuka T
Ann Neurol; 2005 Feb; 57(2):168-75. PubMed ID: 15668962
[TBL] [Abstract][Full Text] [Related]
40. Optimized Quantification of Translocator Protein Radioligand ¹⁸F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers.
Lavisse S; García-Lorenzo D; Peyronneau MA; Bodini B; Thiriez C; Kuhnast B; Comtat C; Remy P; Stankoff B; Bottlaender M
J Nucl Med; 2015 Jul; 56(7):1048-54. PubMed ID: 26025960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
